Peer-Reviewed Study: Highly Bioavailable Curcumin

8ed342b6-417b-4bc1-b8aa-f8344ecd929evideoimages.jpg supplier logo

Highly bioavailable curcumin from CAVACURMIN® empowers your formulation with unique advantages: 40 times better absorption than pure curcumin products and easy formulation into shots, capsules and tablets. Read the clinical human study on the exceptional bioavailability of CAVACURMIN® – published by the European Journal of Nutrition.

* - Indicates required field
Message :
By completing your details to view this free content, you are agreeing to receive follow-up communications from CNS Media and/or third parties regarding this topic
I have read and agree to the Privacy Policy *
Related Content

Wacker Chemie AG


Wacker Chemie AG

Hanns-Seidel-Platz 4





Tel. +49 89 62790

Fax. +49 89 6279-2507


Amino Acids,Chemicals - Encapsulated,Emulsifiers and Emulsifier Systems,Fibers,Nutraceutical and Functional Food Ingredients,Starch and Starch Products

Wacker Biosolutions, Wacker’s life science and biotechnology division, offers a broad range of innovative tailored products and solutions for the life science sector –, particularly for the functional food and nutraceutical industries. 

These include Cavamax® W6 alpha-cyclodextrin, a natural, starch-derived oligosaccharide. It can be added as a fully fermentable dietary fiber to foods and beverages, including carbonated and non-carbonated transparent soft drinks. Cavamax® W6 is scientifically proven to significantly reduce the post-prandial glycaemic response – an effect officially acknowledged by EFSA. Besides, it interacts with triglycerides building up a surfactant-like structure that stabilizes oil-in-water emulsions efficiently. With Cavamax® W6, Wacker thus offers manufacturers a possibility to replace emulsifiers with a soluble fiber.

Furthermore, Wacker offers molecular encapsulation solutions based on our cyclodextrin technology for odor or taste-masking, to stabilize food ingredients against heat and oxidation and to increase the bioavailability of functional ingredients. We have over 15 years of experience in manufacturing and formulating alpha-, beta- and gamma-cyclodextrins. 

Additionally, Wacker produces a high-quality range of non-human, non-animal derived L-cysteine products. Wacker is the world’s only manufacturer of vegetarian-grade cysteine using a patented biotech process.

Articles On FoodIngredientsFirst
Food Ingredients News 13 September 2018

Wacker inaugurates cystine production in Spain

13 Sep 2018 -- Wacker Biosolutions, the life sciences division of the Wacker Group, has begun producing fermentation-generated cystine at its new site in León, Spain. Over the past eighteen months, the division has extensively modernized part of the 800 m³ fermentation capacity acquired there at the end of 2016. 

Food Ingredients News 29 January 2018

Wacker develops novel depositing technology for chewing gum

29 Jan 2018 --- Wacker has developed a new compound to deposit chewing gum which offers a pioneering creative freedom to produce the sugar-free confectionery in an unprecedented variety of shapes, something which the company tips to be a game-changer.

Food Ingredients News 10 January 2018

Haas becomes a member of the Buhler Group

10 Jan 2018 --- The Haas Group, a leader in the field of wafers, cookies, and confectionary production systems, is now officially part of the Bühler Group. Last year, FoodIngredientsFirst reported on the initial acquisition. You can read the full story here

Video Interviews

New depositing technology for chewing gum

13 February 2018

Wacker has developed a new compound to ...


The Role for Novel Emulsifier Systems

14 August 2017 Wacker’s CAVAMAX W6 alphadextrin ...


Innovative Technologies for Future Chewing Gum

07 February 2017 With WACKER’s innovative ...